Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear receptor binding factor 2 pseudogene 3 (NRBF2P3) is a pseudogene—a DNA sequence similar to a known gene but typically nonfunctional due to disabling mutations. It is annotated in gene databases (NCBI Gene ID: 643232), and it is presumed to be related by sequence similarity to the functional gene NRBF2 (Nuclear receptor binding factor 2). Pseudogenes like NRBF2P3 do not encode an active protein product; while some pseudogenes have been found to regulate gene expression or serve as sources for regulatory noncoding RNAs, there is no evidence that NRBF2P3 has such a function. Currently, there is no known therapeutic, diagnostic, or biological significance for NRBF2P3, nor is it a drug target or involved in disease mechanisms. If you are seeking a functional target, you may want to consider NRBF2 (Nuclear receptor binding factor 2), which encodes a protein involved in autophagy and transcriptional regulation. However, NRBF2P3 itself does not meet the criteria for a canonical, actionable target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear receptor binding factor 2 pseudogene 3 (NRBF2P3).